High Th17:Treg ratio may predict complete response to HDIL-2 in the setting of melanoma

by Diller, Maggie L, Mandy, Ford, Delman, Keith A, Lawson, David H
Published 2015

Balancing Inflammation: The Link between Th17 and Regulatory T Cells

by Diller, Maggie L., Kudchadkar, Ragini R., Delman, Keith A., Lawson, David H., Ford, Mandy L.
Published 2016

CD45/CD8 Myeloid Histioid Antigen and Plasma Cell Antibody Immune Response in a Case of Malignant Melanoma

by Abreu-Velez, Ana Maria, Howard, Michael S, Pereyo, Neville Y, Delman, Keith A, Mihm, Martin C, Rizzo, Monica
Published 2012

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

by Andtbacka, Robert H. I., Ross, Merrick, Puzanov, Igor, Milhem, Mohammed, Collichio, Frances, Delman, Keith A., Amatruda, Thomas, Zager, Jonathan S., Cranmer, Lee, Hsueh, Eddy, Chen, Lisa, Shilkrut, Mark, Kaufman, Howard L.
Published 2016